Literature DB >> 18663494

Identification and characterisation of a large senataxin (SETX) gene duplication in ataxia with ocular apraxia type 2 (AOA2).

Larissa Arning1, Ludger Schöls, Huriye Cin, Manfred Souquet, Jörg T Epplen, Dagmar Timmann.   

Abstract

Autosomal recessive cerebellar ataxia with ocular apraxia type 2 (AOA2) is a neurodegenerative disorder characterised by early onset cerebellar ataxia, sensory-motor neuropathy and frequently increased levels of alpha-fetoprotein. We describe a male patient with a phenotype highly suggestive of AOA2, but only one point mutation found by sequencing of the SETX gene. Further analysis revealed a large out-of-frame tandem duplication, encompassing exons 7, 8, 9 and 10. This duplication event occurred obviously by unequal homologous recombination between AluY sequences. Gross SETX deletions or duplications might be an underestimated cause of AOA2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18663494     DOI: 10.1007/s10048-008-0139-z

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  12 in total

1.  Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.

Authors:  C Criscuolo; L Chessa; S Di Giandomenico; P Mancini; F Saccà; G S Grieco; M Piane; F Barbieri; G De Michele; S Banfi; F Pierelli; N Rizzuto; F M Santorelli; L Gallosti; A Filla; C Casali
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

2.  Novel mutations in the senataxin DNA/RNA helicase domain in ataxia with oculomotor apraxia 2.

Authors:  Brent L Fogel; Susan Perlman
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

3.  Analysis of newly identified low copy AluYj subfamily.

Authors:  Eun-Sil Park; Jae-Won Huh; Tae-Hong Kim; Kyoung-Don Kwak; Wook Kim; Heui-Soo Kim
Journal:  Genes Genet Syst       Date:  2005-12       Impact factor: 1.517

4.  Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder.

Authors:  Marie Fernet; Moez Gribaa; Mustafa A M Salih; Mohamed Zein Seidahmed; Janet Hall; Michel Koenig
Journal:  Hum Mol Genet       Date:  2004-12-01       Impact factor: 6.150

5.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

Authors:  Ying-Zhang Chen; Craig L Bennett; Huy M Huynh; Ian P Blair; Imke Puls; Joy Irobi; Ines Dierick; Annette Abel; Marina L Kennerson; Bruce A Rabin; Garth A Nicholson; Michaela Auer-Grumbach; Klaus Wagner; Peter De Jonghe; John W Griffin; Kenneth H Fischbeck; Vincent Timmerman; David R Cornblath; Phillip F Chance
Journal:  Am J Hum Genet       Date:  2004-04-21       Impact factor: 11.025

6.  "Pseudodominant inheritance" of ataxia with ocular apraxia type 2 (AOA2).

Authors:  Ludger Schöls; Larissa Arning; Rebecca Schüle; Jörg T Epplen; Dagmar Timmann
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

7.  Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients.

Authors:  Isabelle Le Ber; Naïma Bouslam; Sophie Rivaud-Péchoux; João Guimarães; Ali Benomar; Céline Chamayou; Cyril Goizet; Maria-Ceù Moreira; Sandra Klur; Mohamed Yahyaoui; Yves Agid; Michel Koenig; Giovanni Stevanin; Alexis Brice; Alexandra Dürr
Journal:  Brain       Date:  2004-01-21       Impact factor: 13.501

8.  Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies.

Authors:  Isabelle Le Ber; Maria-Ceù Moreira; Sophie Rivaud-Péchoux; Céline Chamayou; François Ochsner; Thierry Kuntzer; Marc Tardieu; Gérard Saïd; Marie-Odile Habert; Geneviève Demarquay; Christian Tannier; Jean-Marie Beis; Alexis Brice; Michel Koenig; Alexandra Dürr
Journal:  Brain       Date:  2003-09-23       Impact factor: 13.501

9.  Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.

Authors:  Maria-Céu Moreira; Sandra Klur; Mitsunori Watanabe; Andrea H Németh; Isabelle Le Ber; José-Carlos Moniz; Christine Tranchant; Patrick Aubourg; Meriem Tazir; Lüdger Schöls; Massimo Pandolfo; Jörg B Schulz; Jean Pouget; Patrick Calvas; Masami Shizuka-Ikeda; Mikio Shoji; Makoto Tanaka; Louise Izatt; Christopher E Shaw; Abderrahim M'Zahem; Eimear Dunne; Pascale Bomont; Traki Benhassine; Naïma Bouslam; Giovanni Stevanin; Alexis Brice; João Guimarães; Pedro Mendonça; Clara Barbot; Paula Coutinho; Jorge Sequeiros; Alexandra Dürr; Jean-Marie Warter; Michel Koenig
Journal:  Nat Genet       Date:  2004-02-08       Impact factor: 38.330

10.  MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder.

Authors:  Domenico Delia; Maria Piane; Giacomo Buscemi; Camilla Savio; Silvia Palmeri; Patrizia Lulli; Luigi Carlessi; Enrico Fontanella; Luciana Chessa
Journal:  Hum Mol Genet       Date:  2004-07-21       Impact factor: 6.150

View more
  10 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 2.  The cerebellum, cerebellar disorders, and cerebellar research--two centuries of discoveries.

Authors:  Mario Manto
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

3.  Senataxin mutations and amyotrophic lateral sclerosis.

Authors:  Michio Hirano; Catarina M Quinzii; Hiroshi Mitsumoto; Arthur P Hays; J Kirk Roberts; Patricia Richard; Lewis P Rowland
Journal:  Amyotroph Lateral Scler       Date:  2010-12-29

4.  Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin.

Authors:  Giovanni Airoldi; Andrea Guidarelli; Orazio Cantoni; Chris Panzeri; Chiara Vantaggiato; Sara Bonato; Maria Grazia D'Angelo; Sestina Falcone; Clara De Palma; Alessandra Tonelli; Claudia Crimella; Sara Bondioni; Nereo Bresolin; Emilio Clementi; Maria Teresa Bassi
Journal:  Neurogenetics       Date:  2009-07-11       Impact factor: 2.660

5.  Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon.

Authors:  Vardiella Meiner; Alexander Lossos; Hagit Baris Feldman; Penina Ponger; Alina Kurolap; Israela Lerer; Judith Dagan; Chofit Chai Gadot; Adi Mory; Yael Wilnai; Nino Oniashvili; Nir Giladi; Tanya Gurevich
Journal:  J Mol Neurosci       Date:  2022-06-08       Impact factor: 2.866

Review 6.  DNA repair deficiency and neurological disease.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2009-01-15       Impact factor: 34.870

7.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

8.  Collapsing singletons may boost signal for associating rare variants in sequencing study.

Authors:  Wei Wang; Zhi Wei
Journal:  BMC Proc       Date:  2014-06-17

9.  Aberrant splicing of the senataxin gene in a patient with ataxia with oculomotor apraxia type 2.

Authors:  Brent L Fogel; Ji Yong Lee; Susan Perlman
Journal:  Cerebellum       Date:  2009-12       Impact factor: 3.847

10.  Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2.

Authors:  Veronica Bernard; Martina Minnerop; Katrin Bürk; Friedmar Kreuz; Gabriele Gillessen-Kaesbach; Christine Zühlke
Journal:  BMC Med Genet       Date:  2009-09-11       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.